These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35203637)

  • 41. Body mass and atherogenic dyslipidemia as major determinants of blood levels of B-type natriuretic peptides in Arab subjects with acute coronary syndromes.
    Akanji AO; Suresh CG; Al-Radwan R; Fatania HR
    Metab Syndr Relat Disord; 2009 Dec; 7(6):563-9. PubMed ID: 19642911
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High-throughput screening assay for the quantification of Cer d18:1/16:0, d18:1/24:0, d18:1/24:1, d18:1/18:0, d18:1/14:0, d18:1/20:0, and d18:1/22:0 in HepG2 cells using RapidFire mass spectrometry.
    Dittakavi S; Mahadevan L; Chandrashekar DV; Bhamidipati RK; Suresh J; Dhakshinamoorthy S; Li Z; Baerenz F; Tennagels N; Mullangi R
    Biomed Chromatogr; 2020 May; 34(5):e4790. PubMed ID: 31883352
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ceramide Risk Score in the Evaluation of Metabolic Syndrome: An Additional or Substitutive Biochemical Marker in the Clinical Practice?
    Rigamonti AE; Dei Cas M; Caroli D; Bondesan A; Cella SG; Paroni R; Sartorio A
    Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569827
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Novel Ceramide- and Phosphatidylcholine-Based Risk Score for the Prediction of New-Onset of Hypertension.
    Shoghli M; Lokki AI; Lääperi M; Sinisalo J; Lokki ML; Hilvo M; Jylhä A; Tuomilehto J; Laaksonen R
    J Clin Med; 2023 Dec; 12(24):. PubMed ID: 38137595
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
    Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fas-induced apoptosis in rat thecal/interstitial cells signals through sphingomyelin-ceramide pathway.
    Foghi A; Ravandi A; Teerds KJ; Van Der Donk H; Kuksis A; Dorrington J
    Endocrinology; 1998 Apr; 139(4):2041-7. PubMed ID: 9528992
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association Between Plasma Ceramides and One-Year Mortality in Patients with Acute Coronary Syndrome: Insight from the PEACP Study.
    Li F; Li D; Yu J; Jia Y; Wen J; Li W; Tong Y; Wu J; Wan Z; Cao Y; Zhang Q; Zeng R
    Clin Interv Aging; 2023; 18():571-584. PubMed ID: 37050937
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Predictive value of neutrophil to lymphocyte ratio on long-term outcomes of acute myocardial infarction patients with multivessel disease].
    Xu N; Tang XF; Xu JJ; Yao Y; Song Y; Liu R; Jiang L; Jiang P; Wang HH; Zhao XY; Chen J; Gao Z; Qiao SB; Yang YJ; Gao RL; Xu B; Yuan JQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Jan; 47(1):42-48. PubMed ID: 30669809
    [No Abstract]   [Full Text] [Related]  

  • 49. Plasma ceramides predict all-cause and cause-specific mortality in individuals with type 2 diabetes.
    Liu S; Tham WK; Lee J; Ang K; Zheng H; Chan C; Gurung RL; Tavintharan S; Sum CF; Wenk MR; Torta F; Liu JJ; Lim SC
    J Clin Endocrinol Metab; 2024 Jun; ():. PubMed ID: 38849301
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Occurrence and predictors of left ventricular systolic dysfunction at hospital discharge and in long-term follow-up after acute myocardial infarction treated with primary percutaneous coronary intervention.
    Świątkiewicz I; Magielski P; Woźnicki M; Gierach J; Jabłoński M; Fabiszak T; Koziński M; Sukiennik A; Bronisz A; Kubica J
    Kardiol Pol; 2012; 70(4):329-40. PubMed ID: 22528703
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plasma ceramides independently predict all-cause mortality in men aged 85.
    Strandberg TE; Kivimäki M; Urtamo A; Jyväkorpi S; Laaksonen R
    Age Ageing; 2022 Jun; 51(6):. PubMed ID: 35716045
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ceramide and sphingomyelin species of fibroblasts and neurons in culture.
    Valsecchi M; Mauri L; Casellato R; Prioni S; Loberto N; Prinetti A; Chigorno V; Sonnino S
    J Lipid Res; 2007 Feb; 48(2):417-24. PubMed ID: 17093290
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The predictive value of B-type natriuretic peptide for the mortality from acute myocardial infarction].
    Yang YJ; Mao Y; Ni XH; Chen JL; Gao RL; Chen ZJ
    Zhonghua Nei Ke Za Zhi; 2007 Jun; 46(6):450-3. PubMed ID: 17663815
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Untargeted lipidomics reveal association of elevated plasma C18 ceramide levels with reduced survival in metastatic castration-resistant prostate cancer patients.
    Cattrini C; Manfredi M; Barboro P; Ghirimoldi M; Mennitto A; Martini V; Battioni A; Le Van M; Gobbato S; Branni C; Ayed RB; Pinato DJ; Catalano F; Zanardi E; Boccardo F; Gennari A
    Sci Rep; 2023 Oct; 13(1):17791. PubMed ID: 37853018
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up.
    Selim G; Stojceva-Taneva O; Spasovski G; Georgievska-Ismail L; Zafirovska-Ivanovska B; Gelev S; Dzekova P; Trajcevska L; Trojacanec-Piponska S; Sikole A
    Nephron Clin Pract; 2011; 119(2):c162-70. PubMed ID: 21757955
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Silencing of ceramide synthase 2 in hepatocytes modulates plasma ceramide biomarkers predictive of cardiovascular death.
    Schmidt S; Gallego SF; Zelnik ID; Kovalchuk S; Albæk N; Sprenger RR; Øverup C; Pewzner-Jung Y; Futerman AH; Lindholm MW; Jensen ON; Ejsing CS
    Mol Ther; 2022 Apr; 30(4):1661-1674. PubMed ID: 34400330
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High-sensitivity C-reactive protein and left ventricular remodeling in patients with acute myocardial infarction.
    Uehara K; Nomura M; Ozaki Y; Fujinaga H; Ikefuji H; Kimura M; Chikamori K; Nakaya Y; Ito S
    Heart Vessels; 2003 May; 18(2):67-74. PubMed ID: 12756602
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Absolute and relative risk prediction in cardiovascular primary prevention with a modified SCORE chart incorporating ceramide-phospholipid risk score and diabetes mellitus.
    Hilvo M; Jylhä A; Lääperi M; Jousilahti P; Laaksonen R
    Eur Heart J Open; 2021 Nov; 1(3):oeab010. PubMed ID: 35919880
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessing potential liver injury induced by
    Jia Z; Liu L; Liu J; Fang C; Pan M; Zhang J; Li Y; Xian Z; Xiao H
    Pharm Biol; 2022 Dec; 60(1):1578-1590. PubMed ID: 35949191
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neutrophil-to-lymphocyte Ratio and Its Relation with Markers of Inflammation and Myocardial Necrosis in Patients with Acute Coronary Syndrome.
    Tahto E; Jadric R; Pojskic L; Kicic E
    Med Arch; 2017 Oct; 71(5):312-315. PubMed ID: 29284896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.